159 related articles for article (PubMed ID: 2963759)
1. A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
Friedman AJ; Barbieri RL; Doubilet PM; Fine C; Schiff I
Fertil Steril; 1988 Mar; 49(3):404-9. PubMed ID: 2963759
[TBL] [Abstract][Full Text] [Related]
2. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I
Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.
Friedman AJ; Harrison-Atlas D; Barbieri RL; Benacerraf B; Gleason R; Schiff I
Fertil Steril; 1989 Feb; 51(2):251-6. PubMed ID: 2492232
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
5. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
[TBL] [Abstract][Full Text] [Related]
6. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
Friedman AJ
Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769
[TBL] [Abstract][Full Text] [Related]
7. Fasting serum growth hormone and insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo.
Friedman AJ; Rein MS; Pandian MR; Barbieri RL
Fertil Steril; 1990 Feb; 53(2):250-3. PubMed ID: 2105242
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.
Friedman AJ; Rein MS; Harrison-Atlas D; Garfield JM; Doubilet PM
Fertil Steril; 1989 Nov; 52(5):728-33. PubMed ID: 2509250
[TBL] [Abstract][Full Text] [Related]
9. Histopathological changes in leiomyomata treated with leuprolide acetate.
Upadhyaya NB; Doody MC; Googe PB
Fertil Steril; 1990 Nov; 54(5):811-4. PubMed ID: 2121550
[TBL] [Abstract][Full Text] [Related]
10. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
Scialli AR; Jestila KJ
Fertil Steril; 1995 Aug; 64(2):313-20. PubMed ID: 7615109
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
12. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
Palomba S; Affinito P; Tommaselli GA; Nappi C
Fertil Steril; 1998 Jul; 70(1):111-8. PubMed ID: 9660431
[TBL] [Abstract][Full Text] [Related]
13. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I
Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
[TBL] [Abstract][Full Text] [Related]
14. Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.
Friedman AJ
Fertil Steril; 1989 Jul; 52(1):152-4. PubMed ID: 2501108
[TBL] [Abstract][Full Text] [Related]
15. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS
Fertil Steril; 1992 Aug; 58(2):413-5. PubMed ID: 1633911
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
Lubich LM; Alderman MG; Ros PR
Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
[TBL] [Abstract][Full Text] [Related]
17. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group.
Stovall TG; Muneyyirci-Delale O; Summitt RL; Scialli AR
Obstet Gynecol; 1995 Jul; 86(1):65-71. PubMed ID: 7784025
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
Stovall TG; Ling FW; Henry LC; Woodruff MR
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL
Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
